Nepal | October 01, 2020

Merck says Ebola vaccine to be available at lowest access price for poor nations

Reuters
Share Now:

Merck & Co said on Friday it expects to make licensed doses of its recently approved Ebola vaccine available in the third quarter of 2020 and price the single-dose injection at the lowest possible access price for poor and middle-income countries.

The vaccine, Ervebo, was approved by the US Food and Drug Administration on Thursday, a month after Europe gave its nod to the vaccine, a move that has been hailed by the World Health Organization.

“We have made a commitment to making the vaccine available to GAVI-eligible countries at the lowest possible access price,” Merck spokesman Skip Irvine said. “We have made that commitment but we have not yet established the price for the vaccine.”

Stockpile of 500,00 doses of Ebola vaccine is being established for emergency use in outbreaks of the deadly fever by the GAVI global vaccine alliance, Reuters reported earlier this month. The stockpiling will start with Merck’s Ervebo vaccine.

GAVI, a public-private partnership backed by the Bill & Melinda Gates Foundation, the WHO, the World Bank and UNICEF, arranges bulk buys to reduce vaccine costs for poor countries.

“We are partnering with both GAVI and WHO to put that stockpile in place as quickly as possible,” the company said in a statement, adding that the stockpile of vaccines will be governed and executed by the owner of the stockpile and not by Merck.

The Ebola virus causes haemorrhagic fever and spreads from person to person through direct contact with body fluids. It kills around half of those it infects.

There have been more than 3,000 cases of Ebola, including 2,199 deaths, in the outbreak that was declared in August 2018. The WHO declared it an international emergency in July 2019.

The company said it was working closely with the U.S. government, WHO, UNICEF, and GAVI to prepare against the disease.

Johnson and Johnson’s two-dose vaccine is currently being reviewed by the European regulator. The company is in discussion with the FDA for US approval.

Merck shares rose as much as up 2.8% to record high of $92.55 on Friday.


Follow The Himalayan Times on Twitter and Facebook

Recommended Stories:

More from The Himalayan Times:

In Pursuit of Onions!

Kathmandu, September 28 People queuing without maintaining safe distancing to buy onions at NRs. 60 per kg at the Nepal Food Corporation at Thapathali in Kathmandu on Monday. Photo: Naresh Shrestha/THT Read More...

Body of missing youth found partly devoured by tiger in Rautahat forest

RAUTAHAT: Security personnel in a search operation found body of a youth who had gone missing in a forest in Chandrapur Municipality-6 of Rautahat district. The Nepal Police and Armed Police Force personnel found the body partly devoured by a wild animal in Tildhare forest, four kilometres south Read More...

Symbolic street-drama in support of Dr Govinda KC

KATHMANDU, SEPTEMBER 30 Shilpee Theater performs a symbolic protest street drama on Wednesday in support of Dr Govinda KC, the 63-year-old orthopedic surgeon who is on his fast-unto-death hunger strike at Teaching Hospital, seeking reforms in the medical sector for the 19th time. Photo: Skanda Ga Read More...

common cold

Do we have pre-existing immunity to Covid-19?

KATHMANDU: People who have contracted the common or seasonal cold in the past may be immune to the coronavirus infection, a study suggests. In a study published in the journal mBio, it indicated that the COVID-19 causing SARS-CoV-2 induce memory B cells, which are long-lived immune cells that det Read More...

Man United beat Brighton again, Calvert-Lewin hat-trick

LONDON: Manchester United earned their second win over Brighton & Hove Albion in five days as they booked a place in the League Cup quarter-finals with a 3-0 win at the Amex Stadium on Wednesday. It was much more comfortable for United than Saturday's dramatic last-gasp 3-2 league Read More...

SC hearing against Gautam’s nomination to NA begins

KATHMANDU, SEPTEMBER 30 Constitutional bench of the Supreme Court today began hearing in the case filed against Nepal Communist Party (NCP) Vice-chair Bamdev Gautam’s nomination to the National Assembly. Lawyers representing petitioners, Senior Advocate Dinesh Tripathi and Advocate Badri Raj Read More...

Swindling racket busted, eight members arrested

KATHMANDU, SEPTEMBER 30 Police have nabbed eight persons who were involved in swindling money from people on the pretext of exchanging foreign currency at a rate lower than the market rate. The police came to know about the large scale business of the racketeers and their notorious history fol Read More...

National Examinations Board (NEB) Nepal

Govt still undecided on Grade XII examinations

KATHMANDU, SEPTEMBER 30 Though various alternatives for conducting the stalled exams have been recommended, the government has failed to take a decision to hold Grade XII examinations. The National Examination Board had suggested the government if holding examinations inside classrooms was not Read More...